Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery

Pubmed ID :27223090
Publication Date : //

Activated dendritic cells delivered in tissue compatible biomatrices induce in-situ anti-tumor CTL responses leading to tumor regression.


Dendritic cell (DC) based anti-cancer immunotherapy is well tolerated in patients with advanced cancers. However, the clinical responses seen after adoptive DC therapy have been suboptimal. Several factors including scarce DC numbers in tumors and immunosuppressive tumor microenvironments contribute to the inefficacy of DCs as cellular vaccines. Hence DC based vaccines can benefit from novel methods of cell delivery that would prevent the direct exposure of immune cells to suppressive tumor microenvironments. Here we evaluated the ability of DCs harbored in biocompatible scaffolds (referred to as biomatrix entrapped DCs; beDCs) in activating specific anti-tumor immune responses against primary and post-surgery secondary tumors. Using a preclinical cervical cancer and a melanoma model in mice, we show that single treatment of primary and post-surgery secondary tumors using beDCs resulted in significant tumor growth retardation while multiple inoculations were required to achieve a significant anti-tumor effect when DCs were given in free form. Additionally, we found that, compared to the tumor specific E6/E7 peptide vaccine, total tumor lysate induced higher expression of CD80 and CD40 on DCs that induced increased levels of IFNγ production upon interaction with host lymphocytes. Remarkably, a strong immunocyte infiltration into the host-implanted DC-scaffold was observed. Importantly, the host-implanted beDCs induced the anti-tumor immune responses in the absence of any stromal cell support, and the biomatrix structure was eventually absorbed into the surrounding host tissue. Collectively, these data indicate that the scaffold-based DC delivery may provide an efficient and safe way of delivering cell-based vaccines for treatment of primary and post-surgery secondary tumors.

Authors : Verma Vivek , Kim Young , Lee Min-Cheol , Lee Jae-Tae , Cho Sunghoon , Park In-Kyu , Min Jung Joon , Lee Je Jung , Lee Shee Eun , Rhee Joon Haeng ,

Related products :

Catalog number Product name Quantity
orb82810 Mouse MDC protein CCL22_MDC is a CC chemokine that is produced in B cells, macrophages, monocytederived dendritic cells, activated NK cells and CD4 T cells. It signals through the CCR4 receptor. MDC c 1 mg
orb84823 TNF alpha protein Tumor necrosis factor alpha (TNF alpha) is produced by neutrophils, activated lymphocytes, macrophages, NK cells, LAK cells, astrocytes endothelial cells, smooth muscle cells and som 20
orb82743 Human MDC protein MDC is a CC chemokine that is produced in B cells, macrophages, monocyte-derived dendritic cells, activated NK cells and CD4 T cells. It signals through the CCR4 receptor. MDC chemoa 1 mg
orb84802 TNF alpha protein Tumor necrosis factor alpha (TNF alpha), also called cachectin, is produced by neutrophils, activated lymphocytes, macrophages, NK cells, LAK cells, astrocytes endothelial cells, smo 50
BR804 Breast tumor tissue array, with matched tumor and adjacent normal tissue, 40 cases_80 cores, replaced by BR804a; ihc Anti-Cytokeratin (Low-MW) confirmed
30-622 ING1 is a tumor suppressor protein that can induce cell growth arrest and apoptosis. The protein is a nuclear protein that physically interacts with the tumor suppressor protein TP53 and is a componen 0.1 mg
BR801 Breast tumor tissue array, with matched tumor and adjacent normal tissue, 40 cases_80 cores, replaced by BR804; ihc Anti-Cytokeratin (High MW) confirmed
MC964 Multiple organ tumor tissue array, including TNM, clinical stage and pathology grade, for testing tumor tissue specificity of therapeutic antibodies, 96 cases_96 cores, replacing MC961; ihc Anti-Act
BR804 Breast tumor tissue array, with matched tumor and adjacent normal tissue, replacing BR801, 40 cases_80 cores
BR801 Breast tumor tissue array, with matched tumor and adjacent normal tissue, 40 cases_80 cores, replaced by BR804
GTX25046 Pars Cervicalis tumor (human) : carotid body tumor tissue slides tissue 5 slides
GTX24675 Bone tumor (human) : giant cell tumor (grade I-II) tissue slides tissue 5 slides
GTX25038 Pancreas tumor (human) : islet cell tumor tissue slides tissue 5 slides
GTX25049 Pelvic tumor (human) : malignant mesothelioma tumor tissue slides tissue 5 slides
GTX15413 Ovary tumor (human) : Malignant Tumor adenocarcinoma tissue slides tissue 5 slides
orb82778 Human TNF alpha protein Tumor necrosis factor alpha (TNF-alpha), also called cachectin, is produced by neutrophils, activated lymphocytes, macrophages, NK cells, LAK cells, astrocytes endothelial cell 1 mg
GTX24663 Angioma (human tumor) : glomus tumor tissue slides tissue 5 slides
MC964 Multiple organ tumor tissue array, including TNM, clinical stage and pathology grade, for testing tumor tissue specificity of therapeutic antibodies, 96 cases_96 cores, replacing MC961
31-018 TNFSF10 is a cytokine that belongs to the tumor necrosis factor (TNF) ligand family. This protein preferentially induces apoptosis in transformed and tumor cells, but does not appear to kill normal ce 0.05 mg
T8235442 Paraffin Tissue Section Panel _ Human Tumor, Different Tumor Type, Different Donors, Panel VI, 8 tissue spots 5 slides
T8235441 Paraffin Tissue Section Panel _ Human Tumor, Different Tumor Type, Different Donors, Panel V, 8 tissue spots 5 slides
T8235422 Paraffin Tissue Section Panel _ Human Tumor, Different Tumor Type, Different Donors, Panel VI, 5 tissue spots 5 slides
T8235421 Paraffin Tissue Section Panel _ Human Tumor, Different Tumor Type, Different Donors, Panel V, 5 tissue spots 5 slides
T8235440 Paraffin Tissue Section Panel - Human Tumor, Different Tumor Type, Different Donors, Panel IV, 8 tissue spots 5 slides
T8235437 Paraffin Tissue Section Panel - Human Tumor, Different Tumor Type, Different Donors, Panel I, 8 tissue spots


 

GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45

Fax 0032 16 50 90 45
info@gentaur.com | Gentaur





GENTAUR Ltd.
Howard Frank Turnberry House
1404-1410 High Road
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur

 

 




GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50

Fax 01 43 25 01 60
RCS Paris B 484 237 888

SIRET 48423788800017

BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG

france@gentaur.com | Gentaur

GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: 0035929830070
Fax: (+49) 241 56 00 47 88

Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur

GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com

Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123




GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel:  0208-080893  Fax: 0497-517897
nl@gentaur.com | Gentaur
IBAN: NL04 RABO 0156 9854 62   SWIFT RABONL2U






GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur






ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF

GENTAUR Poland Sp. z o.o.


ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX  058 710 33 48              

poland@gentaur.com | Gentaur

Other countries

Österreich +43720880899

Canada Montreal +15149077481

Ceská republika Praha +420246019719

Danmark +4569918806

Finland Helsset +358942419041

Magyarország Budapest +3619980547

Ireland Dublin+35316526556

Luxembourg+35220880274

Norge Oslo+4721031366

Sverige Stockholm+46852503438

Schweiz Züri+41435006251

US New York+17185132983

GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur